文献速递其他结缔组织病

系统性硬化症患者IgG诱导单核细胞样THP-1细胞促炎促纤维化表型

Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究用系统性硬化症(SSc)患者IgG刺激单核细胞样THP-1细胞,分析分泌组变化。结果显示SSc-IgG显著改变分泌组,向促炎促纤维化表型转变,包括CCL18和CXCL8升高,且表达谱因SSc-IgG供者而异。AP-1驱动CCL18和CXCL8诱导,TAK/IKK-β/NF-κB通路和ERK1/2驱动CXCL8。

要点

  • SSc-IgG可诱导单核细胞样THP-1细胞产生促炎促纤维化表型。
  • CCL18和CXCL8表达调控差异:AP-1驱动两者,TAK/IKK-β/NF-κB和ERK1/2驱动CXCL8。
  • AP-1是单核细胞CCL18基因转录的关键调控因子及潜在治疗靶点。

核心结论

  • SSc-IgG通过诱导单核细胞促炎促纤维化表型参与SSc组织微环境形成。
  • AP-1是单核细胞CCL18基因转录的关键调控因子,为SSc潜在药物治疗靶点。

研究设计与样本

  • 用SSc-IgG刺激单核细胞样THP-1细胞并分析分泌组。
  • 通过药理学方法评估主要促炎通路对SSc-IgG诱导CXCL8和CCL18的意义。

主要发现

  • SSc-IgG显著改变THP-1细胞分泌组,向促炎促纤维化表型转变,包括CCL18和CXCL8升高。
  • CCL18和CXCL8表达谱因SSc-IgG供者个体而异。
  • AP-1驱动CCL18和CXCL8诱导,TAK/IKK-β/NF-κB通路和ERK1/2驱动CXCL8。

临床怎么用

  • 提示SSc-IgG对单核细胞分泌组的调控可能参与SSc促炎促纤维化微环境。
  • AP-1作为CCL18转录关键调控因子,可能成为SSc治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Functional IgG autoantibodies against diverse G protein-coupled receptors, i.e. antibodies with agonistic or antagonistic activity at these receptors, are abundant in human serum. Their levels are altered in patients with SSc, and autoantibodies against angiotensin II receptor 1 (ATR1) and endothelin receptor A (ETA) have been suggested to drive SSc by inducing the chemokines CXCL8 and CCL18 in the blood. The objective of our study is to profile the effect of IgG in SSc (SSc-IgG) on the production of soluble mediators in monocytic cells. METHODS: Monocyte-like THP-1 cells were stimulated with SSc-IgG and their secretome was analysed. Furthermore, the significance of major pro-inflammatory pathways for the induction of CXCL8 and CCL18 in response to SSc-IgG was assessed by a pharmacological approach. RESULTS: Stimulation with SSc-IgG significantly alters the secretome of THP-1 cells towards a general pro-inflammatory and profibrotic phenotype, which includes an increase of CCL18 and CXCL8. The consequent expression profiles vary depending on the individual donor of the SSc-IgG. CCL18 and CXCL8 expression is thus regulated differentially, with AP-1 driving the induction of both CCL18 and CXCL8 and the TAK/IKK-β/NF-κB pathway and ERK1/2 driving that of CXCL8. CONCLUSIONS: Our results suggest that SSc-IgG contributes to the generation of the pro-inflammatory/profibrotic tissue milieu characteristic of SSc by its induction of a respective phenotype in monocytes. Furthermore, our results highlight AP-1 as a critical regulator of gene transcription of CCL18 in monocytic cells and as a promising pharmacological therapeutic target for the treatment of SSc.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Murthy S, Wannick M, Eleftheriadis G, et al. Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells. Rheumatology (Oxford). 2021. PMID: 33230552. doi:10.1093/rheumatology/keaa747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。